Yew Bio-Pharm Group, Inc. Lease, Cost
Yew Bio-Pharm Group, Inc. reported Lease, Cost of $59.70 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2021-11-15
- Yew Bio-Pharm Group, Inc. lease, cost for the quarter ending 2021-09-30 was $19.59K, a 23.47% increase year-over-year.
- Yew Bio-Pharm Group, Inc. lease, cost for the quarter ending 2021-06-30 was $20.07K, a 3.62% increase year-over-year.
- Yew Bio-Pharm Group, Inc. lease, cost for the quarter ending 2021-03-31 was $20.04K, a 3.75% increase year-over-year.
- Yew Bio-Pharm Group, Inc. lease, cost for the quarter ending 2020-12-31 was $19.62K, a 29.19% increase year-over-year.
- Yew Bio-Pharm Group, Inc. lease, cost for fiscal 2020 was $74.17K, a 42.35% decline from fiscal 2019.
- Yew Bio-Pharm Group, Inc. lease, cost for fiscal 2019 was $128.66K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2021-09-30 | $19.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $39.66K derived: sum of 2 quarters · filed 2021-11-15 | $59.70K 10-Q · filed 2021-11-15 | $79.32K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | $20.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $40.11K 10-Q · filed 2021-08-16 | $59.73K derived: sum of 3 quarters · filed 2021-08-16 | $75.60K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-03-31 | $20.04K 10-Q · filed 2021-05-17 | $39.67K derived: sum of 2 quarters · filed 2021-05-17 | $55.53K derived: sum of 3 quarters · filed 2021-11-15 | $74.90K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-12-31 | $19.62K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $35.49K derived: sum of 2 quarters · filed 2021-11-15 | $54.85K derived: sum of 3 quarters · filed 2021-11-15 | $74.17K 10-K · filed 2021-03-30 |
| 2020-09-30 | $15.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $35.23K derived: sum of 2 quarters · filed 2021-11-15 | $54.55K 10-Q · filed 2021-11-15 | $69.74K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $19.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $38.69K 10-Q · filed 2021-08-16 | $53.87K derived: sum of 3 quarters · filed 2021-08-16 | $128.87K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $19.32K 10-Q · filed 2021-05-17 | $34.51K derived: sum of 2 quarters · filed 2021-05-17 | $109.50K derived: sum of 3 quarters · filed 2021-05-17 | $118.47K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $15.19K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $90.18K derived: sum of 2 quarters · filed 2021-03-30 | $99.15K derived: sum of 3 quarters · filed 2021-03-30 | $128.66K 10-K · filed 2021-03-30 |
| 2019-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $83.96K derived: sum of 2 quarters · filed 2020-11-13 | $113.48K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $8.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $38.48K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $29.51K 10-Q · filed 2020-06-29 |